Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Hongkong
  4. Hong Kong Stock Exchange
  5. Genscript Biotech Corporation
  6. Nieuws
  7. Andere talen
    1548   KYG3825B1059

GENSCRIPT BIOTECH CORPORATION

(1548)
  Rapport
Vertraagde tijd Hong Kong Stock Exchange  -  09:08:41 30-01-2023
28.30 HKD   -3.58%
05:49Genscript Biotech's Fase 3 studie voor Myeloma behandeling bereikt primair eindpunt; aandelen dalen met 4%
MT
18/01GenScript ProBio, gesteund door Hillhouse, haalt $224 miljoen op bij Legend Capital en anderen
MR
03/01Chinese toezichthouder aanvaardt Genscript Biotechs nieuwe geneesmiddelenaanvraag voor chimere antigen receptor; aandelen stijgen met 6%.
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op GENSCRIPT BIOTECH CORPORATION
05:49Genscript Biotech's Phase 3 Study for Myeloma Treatment Meets Primary Endpoint; Shares ..
26/01Genscript Biotech's Multiple Myeloma Treatment Generates $55 Million in Net Trade Sales..
25/01Genscript Biotech Corporation Reports Sales Results for the Quarter Ended 31 December 2..
24/01Genscript Biotech Grants Restricted Shares to Non-Executive Directors
18/01Hillhouse-backed GenScript ProBio to raise $224 million from Legend Capital, others
18/01Probio Technology Limited announced that it expects to receive $224 million in funding ..
03/01Chinese Regulator Accepts Genscript Biotech's New Drug Application for Chimeric Antigen..
2022Genscript Biotech Appoints Rotating CEO
2022Genscript Biotech Corporation Announces Chief Executive Officer Changes
2022Genscript Biotech Corporation Announces Redesignation of Dr. Zhang Fangliang from A Non..
2022Cell and Gene Therapy Companies Leverage GenScript's cGMP sgRNA Capability to Accelerat..
2022GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS
2022GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identifica..
2022GenScript Biotech Corporation Partners with Allozymes to Accelerate Protein Discovery a..
2022Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will furth..
2022Genscript Biotech Unit Gets US FDA Nod for Clinical Development of Small Cell Lung Canc..
2022GenScript Named a BioSpace 2023 Best Place to Work
2022Genscript Biotech to Present Data on Multiple Myeloma Therapies in US; Shares Rise 4%
2022GenScript Biotech Unit Gains $55 Million in Q3 Sales from Myeloma Medication; Shares Ri..
2022Genscript Biotech Corporation Reports Sales Results for the Quarter Ended September 30,..
2022Genscript Biotech's U.S. Unit Amends CFO Pay
2022Japan Approves Genscript Biotech's Chimeric Antigen Receptor T Cell Therapy
2022Genscript Bio's H1 Loss Widens on Higher Fair Value Losses
2022GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreak..
2022GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Proce..
2022Genscript Biotech Unit to Hold Research and Development Day in New York; Shares Slip 5%
2022Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30,..
2022GenScript USA Responds to Monkeypox Public-Health Emergency with Real-Time PCR Test
2022GenScript Launches Expedited mRNA Service for Research and Pre-Clinical Applications
2022GenScript Biotech Sees Up to $137 Million H1 Net Loss
2022Genscript Biotech Corporation Provides Earnings Guidance for the Six Months Ended June ..
2022Genscript Biotech Corporation Announces Board Changes
2022Genscript Biotech Unit Completes Follow-On Offering
2022Genscript Bio's Nasdaq-listed Unit Prices Stock Offering to Raise $350 Million
2022GenScript to Host 2nd Annual Gene & Cell Engineering Virtual Summit
2022Genscript Biotech's Nasdaq-listed Unit Plans $250 Million Stock Offering
2022Genscript Biotech Unit Logs $24 Million in Q2 Sales of Immunotherapy; Shares Slip 3%
2022GenScript Biotech Unit Terminates Phase 1 Study for Lymphoma Therapy; Shares Down 3%
2022Genscript Biotech Unit Completes $37 Million Sale of Series B Shares
2022Genscript Biotech Unit Presents Updated Study Results of Cancer Therapy at US Oncology ..
2022GenScript USA Enters Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neut..
2022Genscript Biotech Corporation Signs A Memorandum of Understanding with Singapore Instit..
2022Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5%
2022Chinese Prosecutors Won't File Smuggling Charges Against Genscript Biotech; Shares Slip..
2022Genscript Biotech Corporation Announces Board Changes
2022Genscript Biotech Unit Receives $50 Million Milestone Payment from Janssen Biotech
2022GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DN..
2022Genscript Biotech Widens Loss on Higher R&D Expenses in 2021
2022Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December..
2022Genscript Biotech's Nasdaq-Listed Unit Secures Supply Deal for Cancer Drug With Janssen..
2022US FDA Approves Genscript Biotech's Immunotherapy for Myeloma
2022Genscript Biotech's Nasdaq-Listed Arm Sees up to $397.4 Million Loss in 2021
2022Baidu, Others Poised to Join Hang Seng Index Amid Reshuffle, Analysts Say
2022Genscript Biotech Corporation Provides Earnings Guidance for the Year Ended 31 December..
2022Legend Biotech Expects to Show Adjusted Loss for Full-Year 2021
2022US FDA Suspends Clinical Trial of Genscript Biotech's Nasdaq-Listed Arm for Lymphoma Tr..
2022Genscript Biotech Shells Out $50 Million in Milestone Payments to Janssen Biotech; Shar..
2022Genscript Biotech Awards Restricted Shares to CEO
2021Nasdaq-listed Legend Biotech Raises $345 Million in Share Offering
2021Genscript Biotech Subscribes for $90 Million Shares in Legend Bio's ADS Public Offering..
2021GenScript Biotech Corp. Expands to the United Kingdom with New Offices and Logistics Ce..
2021North American Morning Briefing:Stocks Seen on Hold as F..
2021Hong Kong-Listed Chinese Biotech Stocks Slide on U.S. Sanction Fears
2021Nasdaq-listed Legend Biotech Plans $300 Million in Stock Offering; Parent Genscript Sha..
2021Genscript Biotech's Nasdaq-Listed Arm Presents Clinical Trial Data for Investigational ..
2021Partner of Genscript's Nasdaq-Listed Arm Submits New Drug Application for Multiple Myel..
2021Genscript Biotech : Launches Closed-End Double-Stranded DNA Service for CRISPR
2021Genscript Biotech's Nasdaq-listed Unit Widens Loss in Q3; Shares Soar 4%
2021GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR
2021Genscript Launches Closed-End Double-Stranded DNA Service for CRISPR
2021Genscript's Nasdaq-Listed Arm to Present 12 Sponsored Studies at American Society of He..
2021US FDA Extends Approval Target Date for Genscript Biotech's Myeloma Drug; Shares Fall 8..
2021Genscript Biotech : Unit Signs Deal for License Application, Commercia..
2021Genscript Biotech : Nasdaq-listed Arm to Present Preclinical, Clinical..
2021Genscript Biotech : Bio's Nasdaq-Listed Unit to Hold Inaugural R&D Day..
2021Genscript Biotech : H1 Loss Narrows on 38% Revenue Growth
2021Genscript Biotech : Nasdaq-Listed Arm Gets Regulatory OK to Start Phas..
2021Genscript Biotech : Unit Issues 300 Million Shares to Hillhouse Capita..
2021Genscript Biotech : Reports First Half 2021 Results
2021Genscript Biotech : Reports 2021 Interim Financial Results
2021Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30,..
2021Discloseable Transactions : Deemed disposal of equity interest in probio cayman
2021Genscript Biotech Corporation Announces Notice of Allowance for U.S. Patent Application
2021Genscript : to Host Gene & Cell Engineering Virtual Summit
2021Genscript Biotech : Bio's Nasdaq-Listed Unit Files Shelf Registration ..
2021Genscript Biotech : Unit Sets Up Cellular Therapy Manufacturing Facili..
2021Duke-NUS Medical School and GenScript Biotech Corporation Announce Notice of Allowance ..
2021Genscript Biotech : Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Ap..
2021Genscript Biotech : Controlling Shareholder Completes Disposal of Stak..
2021Genscript Biotech : Issues 103 Million Shares to Hillhouse Capital; St..
2021Hillhouse Capital Management, Ltd. completed the acquisition of 2.99% stake in Genscrip..
2021Genscript : Biotech and Ligand Pharmaceuticals Enter into Global OmniAbģ Licensing Agreeme..
2021GenScript Biotech Corporation and Ligand Pharmaceuticals Incorporated Enters into Globa..
2021Genscript Biotech : Grants Share Options, Restricted Shares; Shares Ra..
2021Genscript Biotech's Nasdaq-listed Unit Readies to Present Study Results of Myeloma Drug..
2021US FDA to Prioritize Review of Genscript Biotech's Myeloma Drug
2021Genscript Biotech Corporation Updates on the Investigation by the Zhenjiang Customs Ant..
2021Genscript Biotech Closes Sale of $300 Milion Worth of Legend Biotech Shares to Hillhous..
2021Hong Kong Stocks End Flat Ahead of Index Review Results; Genscript Biotech Gains 3%
2021Genscript Biotech Unit Gets $15 Million as Marketing Application for Cancer Drug Accept..
Volgende evenement op GENSCRIPT BIOTECH CORPORATION